#DecemberIssue | This #Perspective proposes that localization of #inflammation to #bone in #ankylosing #spondylitis and to ligamentous soft tissue in #axial #psoriatic #arthritis has implications for diagnosis, pathology and treatment. go.nature.com/4847GIb

🎉🎊 New! 2023 EULAR recommendations for management of fatigue is just published! Highlights 🔍🔎 ➡️ Regular assessment of fatigue severity 📈 📉 ➡️ Offering fatigue management, including non-pharmacological 🏃‍♀️ and pharmacological 💊 interventions Link: pulse.ly/3hmmie6dn6

Full Read comprehensive review by Isenberg et al-what Rx works in SLE; review of RCT data on approved & developing drugs: - Obinutuzumab - Dapirolizumab - Deucravacitinib - Litifilimab - Atacicept - Telitacicept bit.ly/3TyKbTh

Can rheumatologists unequivocally diagnose axSpA in patients with chronic back pain of <2 y duration? 2-year data from #SPACE cohort 🔴 Definite axSpA diagnosis 30% (SIJ MRI+++) 🔴 Uncertain: 5%–30% 🔴 Repeating MRI may be worthwhile in ♂️ HLA-B27+ 👉 bit.ly/4b9voVu

ASAS #PerSpA publication Findings: Prevalence of patients with enthesitis across SpA subtypes differs depending on disease and enthesitis index used Read more here: pubmed.ncbi.nlm.nih.gov/37291655/

Continue to love this myositis diagram. Seems to be getting ever more complicated though! LisaChristopherStine Dr. John Cush #RNL2024

✅ It is for me an immense honor to be invited to participate to the 2024 Kyiv #Rheumatology Forum in #Ukraine. While I will not be able to attend in person, -for obvious reasons-, it is an immense privilege to be invited to talk about #lupus in these difficult times 🇺🇦

✅ LIVE: Very honored to give a #lupus lecture for #Ukraine at Kyiv #Rheumatology meeting 2024. During these very insecure times -at the global level-, we are all thinking of our colleagues - wherever they are - taking care of patients in very difficult conditions. #Europe 🇪🇺

MSUS guidance in PsA: 💡MSUS can identify early PsA 💡MSUS can predict flares 💡MSUS can confirm flare when PE is equivocal 💡Caution w/ age,BMI and biomechanical stress on entheseal findings. 💡MSUS informs pts on disease activity and assists im shared decision making. Amazing

✅ This is one of the MOST IMPORTANT 🔥 #ACR2024 Update for #Lupus. Updated ACR #recommendations for lupus #nephritis ⬇️

#SLE #Lupus Nepthritis #ACR24 #Rheumatology #MedTwitter

In a new summary of its 2024 Guideline for the Screening, Treatment, and Management of Lupus Nephritis, the ACR offers 41 recommendations for clinicians treating the condition. First author, Dr. Lisa Sammaritano, tells us more. #lupusnephritis

#ACR24 | Review of Neurosarcoid  By Dr. Shruti Agnihotri & Dr. Huzaefah Syed Neurosarcoidosis 🧠 • Review clinical manifestations • Diagnostic workup: imaging, CSF, biopsy • Treatment algorithm including refractory disease #Sarcoidosis #Neurosarcoidosis #Rheumatology

Late-onset systemic #lupus erythematosus (SLE) is the term used when the disease is first diagnosed after 50–65 years, although onset after 50 years is more biologically plausible as this roughly corresponds to the age of menopause. Late-onset #SLE comprises nearly 20% of all

Announcing $10,000 Mentored Fellowship Award for rheumatology trainees to fund #spondyloarthritis research projects. Awards announced at the SPARTAN Annual Meeting in May. Do not need to be SPARTAN member to be eligible. App Due: February 28, 2025 Details: spartangroup.org/mentored-fello…

✅ I have just finished preparing my #CORA2025 Autoimmunity Network debate supporting the idea that OF COURSE WE SHOULD NOT PRESCRIBE an early combination of treatments or TRIPLE THERAPY in #LUPUS #NEPHRITIS. Let's make the Standard Of Care GREAT again (SOCGA) 💪

Treatment of rheumatologic complications (inflammatory arthritis, polymyalgia rheumatica and myositis/myalgia) from immune checkpoint inhibitors. Review by Cappelli LC et al pubmed.ncbi.nlm.nih.gov/33186490/

Full read review and overview of Fibromyalgia - manifestations, pathophysiology, treatments and guidelines. Multidisciplinary, patient-centered treatment should includes a combination of pharmacological and nonpharmacological options. buff.ly/40DCBZH

The KDIGO IgAN session starts soon! Join us in Amaltas B Hall-B101B at 13:00 or watch the live stream: theisn.org/wcn/industry/l… #KDIGO #IgAN #ISNWCN

🔎 Complete Ankylosis in Axial Spondyloarthritis: A Rare but Preventable Outcome This new case in the ASAS Online Case Library provides key insights into late-stage axSpA. 📌 Explore the case here: cases.asas-group.org/497371.html #AxSpA #Rheumatology #ASAS #SpinalAnkylosis #Radiology